en · de · es · fr · pt
cardarine-notes.peptides6579.com › Topic › Mechanism And Detection — Reference Sheet

Mechanism And Detection — Reference Sheet

By Editorial Desk · published 2026-05-25 · last reviewed 2026-06-22 · Topic

PPARδ agonist raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

This page was last updated on 2026-06-22 and is reviewed periodically as new material appears.

Mechanism and Detection

Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.

GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.

Cardarine as Investigational PPARδ Agonist

Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.

Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.

The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.

Cardarine at a glance

PropertyValueNotes
Molecular targetPPAR delta (NR1C2)Ligand-activated nuclear receptor.
Primary tissues studiedSkeletal muscle, liver, adiposeEffects on fatty acid oxidation and energy use.
Typical detection matrixUrineUsed in anti-doping analysis.
Common analytical methodLC-MS/MSDetects parent compound and metabolites.
Sport regulatory classProhibited at all timesListed as a metabolic modulator by WADA.

Background and Research Context

PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.

In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.

Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.

Related pages on this site

Background and Regulatory History

Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.

Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.

Mechanism and Laboratory Detection

Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.

GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.

Background from the literature

A drop in progesterone levels is possibly one step in the onset of labor. In addition, progesterone inhibits lactation during pregnancy. The fall in progesterone levels following delivery is one of the triggers for milk production. The fetus metabolizes placental progesterone in the production of adrenal steroids.

=== Viral vectors, viral-like particles, and biological nanocarriers === Viruses can be used to deliver genes for genetic engineering or gene therapy. Commonly used viruses include adenoviruses, retroviruses, and various bacteriophages. The surface of the viral particle can also be modified with ligands to increase targeting capabilities. While viral vectors can be used to great efficacy, one concern is that may cause off-target effects due to its natural tropism. This usually requires replacing the proteins causing virus-cell interactions with chimeric proteins. In addition to using viruses, drug molecules can also be encapsulated in protein particles derived from the viral capsid, or virus-like particles (VLPs). VLPs are easier to manufacture than viruses, and their structural uniformity allows VLPs to be produced precisely in large amounts. VLPs also have easy-to-modify surfaces, allowing the possibility for targeted delivery. There are various methods of packaging the molecule into the capsid; most take advantage of the capsid's ability to self-assemble. One strategy is to alter the pH gradient outside the capsid to create pores on the capsid surface and trap the desired molecule. Other methods use aggregators such as leucine zippers or polymer-DNA amphiphiles to induce capsid formation and capture drug molecules. It is also possible to chemically conjugate of drugs directly onto the reactive sites on the capsid surface, often involving the formation of amide bonds.

This may conflict with other product ions, such as the association product from the reaction with carbon dioxide, H3O+CO2, and the single hydrate of the protonated acetaldehyde ion, C2H5O+(H2O), which also appear at m/z 63, and so it may be unidentifiable in certain samples. However dimethyl sulfide reacts with NO+ by charge transfer, to produce the ion C2H6S+, which appears at m/z 62 in resulting spectra, whereas carbon dioxide does not react with NO+, and acetaldehyde donates a hydride ion, giving a single product ion at m/z 43, C2H3O+, and so dimethyl sulfide can be easily distinguished. Over recent years, advances in SIFT-MS technology have vastly increased the sensitivity of these devices such that the limits of detection now extend down to the single-digit-ppt level.

On the nuclear weapons front, the United States and the Soviet Union pursued nuclear rearmament and developed long-range weapons with which they could strike the territory of the other. In August 1957, the Soviets successfully launched the world's first intercontinental ballistic missile (ICBM), and in October they launched the first Earth satellite, Sputnik 1. This led to what became known as the Sputnik crisis. The Central Intelligence Agency described the orbit of Sputnik 1 as a "stupendous scientific achievement" and concluded that the USSR had likely perfected an intercontinental ballistic missile (ICBM) capable of reaching 'any desired target with accuracy'. The launch of Sputnik inaugurated the Space Race. This led to a series of historic space exploration milestones, and most notably the Apollo Moon landings from 1969 by the United States, which astronaut Frank Borman later described as "just a battle in the Cold War." The public's reaction in the Soviet Union was mixed. The Soviet government limited the release of information about the lunar landing, which affected the reaction. A portion of the populace did not give it any attention, and another portion was angered by it. A major Cold War element of the Space Race was satellite reconnaissance, as well as signals intelligence to gauge which aspects of the space programs had military capabilities.

=== Documentaries === The 2013 documentary Oxyana covers prescription drug abuse in rural Southern West Virginia, based in the town of Oceana and surrounding Wyoming County, specifically highlight the abuse of oxycodone. In 2017, the short documentary film Heroin(e) was released and nominated for the Academy Award for Best Documentary Short Subject at the 90th Academy Awards. The film focuses on the opioid epidemic's effects on Huntington, West Virginia, where the overdose rate was 10 times the US average. In 2020, Netflix released the documentary series The Pharmacist, which covers the efforts of Dan Schneider, a small-town pharmacist in Poydras, Louisiana, to identify his son's killer and his gathering of evidence against a prolific "pill mill" doctor in New Orleans, leading to an investigation against Purdue Pharma's aggressive corporate sales tactics of OxyContin. In 2021, HBO released The Crime of the Century, a 2-part documentary directed by Alex Gibney that follows the opioid epidemic and the political operatives, government regulations and corporations that enable the abuse of opioids, particularly the Sackler family and Purdue Pharma, and received positive reviews." All the Beauty and the Bloodshed is a 2022 documentary about the activist Nan Goldin's fight against the Sackler family for their role in the opioid epidemic in the United States.. At the 95th Academy Awards, the film was nominated for Best Documentary Feature and was awarded a Peabody Award at the 84th ceremony in 2023.

Sources: en.wikipedia.org

Reference notes

=== Differential diagnosis === While Gilbert syndrome is considered harmless, it is clinically important because it may give rise to a concern about a blood or liver condition, which could be more dangerous. However, these conditions have additional indicators:

Photosynthesis is the synthesis of carbohydrates from sunlight and carbon dioxide (CO2). In plants, cyanobacteria and algae, oxygenic photosynthesis splits water, with oxygen produced as a waste product. This process uses the ATP and NADPH produced by the photosynthetic reaction centres, as described above, to convert CO2 into glycerate 3-phosphate, which can then be converted into glucose. This carbon-fixation reaction is carried out by the enzyme RuBisCO as part of the Calvin–Benson cycle. Three types of photosynthesis occur in plants, C3 carbon fixation, C4 carbon fixation and CAM photosynthesis. These differ by the route that carbon dioxide takes to the Calvin cycle, with C3 plants fixing CO2 directly, while C4 and CAM photosynthesis incorporate the CO2 into other compounds first, as adaptations to deal with intense sunlight and dry conditions. In photosynthetic prokaryotes the mechanisms of carbon fixation are more diverse. Here, carbon dioxide can be fixed by the Calvin–Benson cycle, a reversed citric acid cycle, or the carboxylation of acetyl-CoA. Prokaryotic chemoautotrophs also fix CO2 through the Calvin–Benson cycle, but use energy from inorganic compounds to drive the reaction.

Both the Greek and Roman civilizations practiced ivory carving to make large quantities of high-value works of art, precious religious objects, and decorative boxes for costly objects. Ivory was often used to form the white of the eyes of statues. There is some evidence of either whale or walrus ivory used by the ancient Irish. Solinus, a Roman writer in the 3rd century claimed that the Celtic peoples in Ireland would decorate their sword-hilts with the 'teeth of beasts that swim in the sea'. Adomnan of Iona wrote a story about St Columba giving a sword decorated with carved ivory as a gift that a penitent would bring to his master so he could redeem himself from slavery. The Syrian and North African elephant populations were reduced to extinction, probably due to the demand for ivory in the Classical world. The Chinese have long valued ivory for both art and utilitarian objects. Early reference to the Chinese export of ivory is recorded after the Chinese explorer Zhang Qian ventured to the west to form alliances to enable the eventual free movement of Chinese goods to the west; as early as the first century BC, ivory was moved along the Northern Silk Road for consumption by western nations. Southeast Asian kingdoms included tusks of the Indian elephant in their annual tribute caravans to China. Chinese craftsmen carved ivory to make everything from images of deities to the pipe stems and end pieces of opium pipes.

In the early 2000s, a link between bisphosphonate use and impaired bone physiology was noted. The strong inhibition of osteoclast function precipitated by bisphosphonate therapy can lead to inhibition of normal bone turnover, leading to impaired wound healing following trauma (such as dental surgery) or even spontaneous non-healing bone exposure. Because bisphosphonates are preferentially deposited in bone with high turnover rates, it is possible that the levels of bisphosphonate within the jaw bones are selectively elevated. With the advent of implant dentistry, more dental patients are undergoing therapies in the oral cavity that involve bone healing, such as surgical implant placement and bone grafting procedures. In order to evaluate the risk of osteonecrosis for a patient taking bisphosphonates, use of the CTX biomarker was introduced in 2000 by Rosen.

Sources: en.wikipedia.org

Frequently asked questions

How does cardarine work in the body?

It binds to and activates PPAR delta, a nuclear receptor that controls expression of genes related to fatty acid oxidation. This mechanism can alter energy metabolism in animal models. It is not a direct stimulant or fat-burning enzyme.

Did human trials show benefits?

Early-stage trials examined lipid and glucose markers, but the development program was discontinued. Published human results are limited and do not support approved use for any indication. Claims of performance or health benefits remain unproven.

Can anti-doping tests detect cardarine?

Yes. Laboratories use LC-MS/MS to detect GW501516 and its metabolites in urine. Detection depends on timing and sensitivity, but the substance is banned at all times.

What is cardarine?

Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.

Network